Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.13Price to Sales
VS
Market
Sector
Industry
History
$ 8.24Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information
Ticker
FENCCompany Name
FENNEC PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFENNEC PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FENC - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 237.4M | 7.13 | $ 33.3M |
| 3/31/2025 | $ 174.83M | 5.66 | $ 30.91M |
| 12/31/2024 | $ 178.53M | 3.76 | $ 47.54M |
| 9/30/2024 | $ 117.68M | 2.38 | $ 49.35M |
| 6/30/2024 | $ 160.08M | 3.27 | $ 48.89M |
| 3/31/2024 | $ 200.54M | 4.46 | $ 44.95M |
| 12/31/2023 | $ 301.35M | 14.18 | $ 21.25M |
| 9/30/2023 | $ 206.42M | 15.82 | $ 13.05M |
| 6/30/2023 | $ 215.72M | 33 | $ 6.54M |
| 3/31/2023 | $ 198.41M | 61.77 | $ 3.21M |
Key Performance Insights, Last 5 Years
- FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, FENNEC PHARMACEUTICALS INC's average P/S has been 314.57.
- The median P/S for FENNEC PHARMACEUTICALS INC during this period was 15.82
- FENNEC PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 1.42K.
- The lowest P/S recorded by FENNEC PHARMACEUTICALS INC in the same timeframe 2.38
FENNEC PHARMACEUTICALS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for FENNEC PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 211.64M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] FENC - Price to Sales, Last 5 years
2.38
Minimum
Sep 30, 2024
1.42K
Maximum
Sep 30, 2021
314.57
Average
15.82
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |